- Home
- CXM vs OCUL Comparison
CXM vs OCUL Comparison
Compare CXM & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CXM | OCUL |
|---|---|---|
| Founded | 2009 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.5B |
| IPO Year | 2021 | 2014 |
Fundamental Metrics
Financial Performance| Metric | CXM | OCUL |
|---|---|---|
| Price | $6.11 | $6.29 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 9 | 12 |
| Target Price | $8.44 | ★ $26.00 |
| AVG Volume (30 Days) | 2.3M | ★ 3.5M |
| Earning Date | 12-02-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.05 | N/A |
| Revenue | ★ $857,200,000.00 | $1,990,000.00 |
| Revenue This Year | $1.19 | $1.71 |
| Revenue Next Year | $3.46 | $93.12 |
| P/E Ratio | $116.70 | ★ N/A |
| Revenue Growth | ★ 7.64 | 3.48 |
| 52 Week Low | $4.72 | $6.23 |
| 52 Week High | $8.28 | $16.44 |
Technical Indicators
Market Signals| Indicator | CXM | OCUL |
|---|---|---|
| Relative Strength Index (RSI) | 64.08 | 26.48 |
| Support Level | $5.57 | $6.23 |
| Resistance Level | $8.28 | $9.93 |
| Average True Range (ATR) | 0.21 | 0.42 |
| MACD | 0.14 | -0.05 |
| Stochastic Oscillator | 95.93 | 15.36 |
Price Performance
Historical ComparisonAbout CXM Sprinklr Inc.
Sprinklr Inc is engaged in enabling customer-facing teams, from Customer Service to Marketing, to collaborate across internal silos, communicate across digital channels, and leverage AI to deliver customer experiences at scale, all on one unified AI-based platform. It focuses on empowering companies to deliver next-generation, unified engagement journeys that reimagine the customer's experience. Its products include Sprinklr Service, Sprinklr Social, Sprinklr Insights, and Sprinklr Marketing. The company operates in the Americas, EMEA, and other countries. It derives maximum revenue from the Americas.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.